AQP12B and bladder transitional cell carcinoma: Taken together, these results nominate AQP12B as a plausible expression-based prognostic marker in TCGA BLCA and provide a rationale for multivariable validation in Cox models adjusted for clinical covariates (age, sex, and stage) and, where possible, external cohort replication.